RxDoctor Payments Data

Peter Stein, MD

Hand Surgery · Great Neck, NYNPI 1215977277

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $105,675 of the $131,000 with a category attached, or 80.7%. Endo Pharmaceuticals Inc. accounts for 63.8% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $33,867, 2.2 times the $15,668 reported in 2019. Among hand surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$131,000in general payments, 2019–2025

Across 178 payments — averaging $735.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Endo Pharmaceuticals Inc.$84K
  • Endo USA, Inc.$45K
  • Medartis Inc.$1K
  • Bioventus LLC$448
  • Hitachi Healthcare Americas Corp.$176
  • Orthofix Medical, Inc.$68
  • plus $184 from 8 others

What the payments were for

  • Consulting fees$4,0653%
  • Speaking & faculty fees$105,67581%
  • Travel & lodging$14,94711%
  • Food & beverage$6,1375%
  • Entertainment$1760%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$131,000 in reported general payments places this provider in the 95th percentile of 178 hand surgery providers in New York.

See all hand surgery providers in New York

Medicare billing

Part B allowed, 2024
$896,030
Medicare patients
1,505
Services billed
8,447

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone13$113
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$76
Meloxicam13$38

Paid to pharmacies, not to this prescriber.

Other hand surgery in Great Neck

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →